Get the Stockscreener App
0.8284
3.07%
0.0247
After Hours:
.85
0.0216
+2.61%
Sutro Biopharma Inc stock is traded at $0.8284, with a volume of 545.38K.
It is up +3.07% in the last 24 hours and down -5.53% over the past month.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
See More
Previous Close:
$0.8037
Open:
$0.8387
24h Volume:
545.38K
Relative Volume:
1.12
Market Cap:
$70.23M
Revenue:
$153.73M
Net Income/Loss:
$-106.79M
P/E Ratio:
-0.4654
EPS:
-1.78
Net Cash Flow:
$-115.93M
1W Performance:
-4.85%
1M Performance:
-5.53%
6M Performance:
+37.52%
1Y Performance:
-78.14%
1-Day Range:
$0.7939
$0.86
1-Week Range:
$0.7884
$0.8922
52-Week Range:
$0.5231
$4.60
Sutro Biopharma Inc Stock (STRO) Company Profile
Name
Sutro Biopharma Inc
Sector
Industry
Phone
650-392-8412
Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.8284 | 68.13M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-16-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-17-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-14-25 | Downgrade | BofA Securities | Buy → Underperform |
| Mar-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Mar-14-25 | Downgrade | Wedbush | Outperform → Neutral |
| May-08-24 | Initiated | BofA Securities | Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-06-23 | Initiated | Oppenheimer | Outperform |
| Mar-21-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-18-22 | Resumed | Wells Fargo | Overweight |
| Jun-18-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Sep-02-20 | Initiated | Jefferies | Buy |
| Jul-16-20 | Initiated | Wells Fargo | Overweight |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Oct-07-19 | Initiated | BTIG Research | Buy |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Apr-29-19 | Initiated | H.C. Wainwright | Buy |
| Oct-22-18 | Initiated | JMP Securities | Mkt Outperform |
| Oct-22-18 | Initiated | Piper Jaffray | Overweight |
| Oct-22-18 | Initiated | Wedbush | Outperform |
View All
Sutro Biopharma Inc Stock (STRO) Latest News
Sutro Biopharma Inc. recovery potential after sell offWeekly Stock Recap & Precise Entry and Exit Recommendations - newser.com
Why Sutro Biopharma Inc. stock is considered a top pickJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Will Sutro Biopharma Inc. stock recover after recent dropJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Does Sutro Biopharma Inc. show high probability of rebound2025 Macro Impact & Technical Confirmation Alerts - newser.com
Key resistance and support levels for Sutro Biopharma Inc.July 2025 Review & Free Safe Capital Growth Stock Tips - newser.com
Will earnings trigger a reversal in Sutro Biopharma Inc.2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
How Sutro Biopharma Inc. (S09) stock reacts to monetary easingJuly 2025 Review & Daily Technical Forecast Reports - newser.com
Sutro Biopharma Inc. stock trend forecastJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Why Sutro Biopharma Inc. stock appeals to dividend seekersJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Will Sutro Biopharma Inc. stock outperform Nasdaq indexJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
Can Sutro Biopharma Inc. (S09) stock deliver strong annual returnsJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Sutro Biopharma's (STRO) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat
Sutro Biopharma’s (STRO) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
What analysts say about Sutro Biopharma Inc S09 stockSector Leadership Analysis & Crush the Market with Breakout Winners - earlytimes.in
Sutro Biopharma Inc. stock outlook for YEARWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
Combining machine learning predictions for Sutro Biopharma Inc.July 2025 Closing Moves & Target Return Focused Stock Picks - newser.com
Top chart patterns to watch in Sutro Biopharma Inc.Weekly Stock Recap & Real-Time Market Sentiment Alerts - newser.com
Will Sutro Biopharma Inc. stock deliver better than expected guidance2025 Risk Factors & Fast Gain Stock Tips - newser.com
How Sutro Biopharma Inc. (S09) stock reacts to fiscal policies2025 Top Gainers & High Conviction Investment Ideas - newser.com
Will a bounce in Sutro Biopharma Inc. offer an exitPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
Is Sutro Biopharma Inc. (S09) stock a momentum leaderWall Street Watch & Capital Efficient Trade Techniques - newser.com
Will Sutro Biopharma Inc. continue its uptrendMarket Risk Report & Safe Entry Momentum Stock Tips - newser.com
What analysts say about Sutro Biopharma Inc stockHigh Dividend Yield Stocks & High Yield Trading Alerts - earlytimes.in
What technical patterns form on Sutro Biopharma Inc. (S09) stock chartsWeekly Risk Summary & Proven Capital Preservation Tips - newser.com
Will Sutro Biopharma Inc. stock benefit from infrastructure spendingTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
What’s next for Sutro Biopharma Inc. stock priceJuly 2025 Trends & Momentum Based Trading Ideas - newser.com
Leading vs lagging indicators on Sutro Biopharma Inc. performanceQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Is Sutro Biopharma Inc. stock attractive for retirement portfoliosMarket Volume Summary & Consistent Return Investment Signals - newser.com
Bay Area biotech company, down from $1B to $78M, lays off a third of workers - SFGATE
Sutro Biopharma trims workforce again to extend cash runway | Pharmaceutical | The Pharmaletter - The Pharma Letter
Sutro Biopharma Inc Stock (STRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sutro Biopharma Inc Stock (STRO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Leyman Barbara | Chief Business Officer |
Jul 08 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
25,000 |
| Chung Jane | Chief Executive Officer |
Aug 09 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
117,058 |
| ALBINI EDWARD C | CFO AND SECRETARY |
May 15 '25 |
Option Exercise |
0.00 |
44,719 |
0 |
176,800 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):